MET and cancer: Consistent with expectations, canonical luminal genes such as ESR1, GATA3, FOXA1, TFF1 and IGF1R were higher in ER+ samples compared to triple negative samples, while proliferation and mesenchymal genes such as SPRY2, SNAI2, FOSL1, MET and BUB1 were higher in triple negative cancers.